16+
Major trials tracked
Antibody-drug conjugates · Live ClinicalTrials.gov data
Sacituzumab govitecan (Trodelvy) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 sacituzumab govitecan (Trodelvy) trials on ClinicalTrials.gov by enrolment, 8 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.
6
Phase 3 trials
8
Actively recruiting
Dec 2026
Next phase 3 primary completion
7,156
Participants across trials
Gilead Sciences
Lead sponsor by trial count
sacituzumab govitecan (16)16 active2019–2034
sacituzumab govitecan
'19
'21
'23
'25
'27
'29
'31
'33
sacituzumab govitecan
TROPiCS-03P2
SASCIAP3
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)P3
Scalp Cooling in MBCP2
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)P2
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)P3
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)P2
Circulating Tumor DNA to Guide Changes in Standard of Care ChemotherapyP2
ASCENT-GYN-01P3
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment ExhaustionP2
Optimal Application Timing of ADC Drugs for Advanced Breast CancerP2
A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBCP2
OASISP2
YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast CancerP3
ADAPT-TN-IVP3
PROBEP2
Upcoming readouts
13 ahead · sacituzumab govitecan
Select a trial to load its full ClinicalTrials.gov record.
Key sacituzumab govitecan trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track sacituzumab govitecan with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for sacituzumab govitecan?
- ClinicalTrials.gov lists more than 16 phase 2–4 sacituzumab govitecan trials. This page tracks the 16 largest by enrolment: 10 phase 2, 6 phase 3, and 0 phase 4 among them, with 8 actively recruiting. Updated daily.
- Are there clinical trials for Trodelvy?
- Trodelvy is the brand name for sacituzumab govitecan, so sacituzumab govitecan trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 sacituzumab govitecan trials. This page tracks the 16 largest by enrolment: 10 phase 2, 6 phase 3, and 0 phase 4 among them, with 8 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare sacituzumab govitecan against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
